175 related articles for article (PubMed ID: 31077643)
1. Relationships between concomitant biologic DMARDs and prednisolone administration and blood tacrolimus exposure or serum CYP3A4/5-related markers in rheumatoid arthritis patients.
Naito T; Ohshiro J; Sato H; Torikai E; Suzuki M; Ogawa N; Kawakami J
Clin Biochem; 2019 Jul; 69():8-14. PubMed ID: 31077643
[TBL] [Abstract][Full Text] [Related]
2. Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients.
Hoshikawa K; Naito T; Akutsu S; Saotome M; Maekawa Y; Kawakami J
Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):353-363. PubMed ID: 31652395
[TBL] [Abstract][Full Text] [Related]
3. Comparative performance of oral midazolam clearance and plasma 4β-hydroxycholesterol to explain interindividual variability in tacrolimus clearance.
Vanhove T; de Jonge H; de Loor H; Annaert P; Diczfalusy U; Kuypers DR
Br J Clin Pharmacol; 2016 Dec; 82(6):1539-1549. PubMed ID: 27501475
[TBL] [Abstract][Full Text] [Related]
4. Relationships between endogenous CYP3A markers and plasma amlodipine exposure and metabolism in early postpartum and non-peripartum women with hypertension.
Taguchi R; Naito T; Kubono N; Ogawa N; Itoh H; Kawakami J
Pregnancy Hypertens; 2019 Jul; 17():209-215. PubMed ID: 31487643
[TBL] [Abstract][Full Text] [Related]
5. ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis.
Naito T; Mino Y; Aoki Y; Hirano K; Shimoyama K; Ogawa N; Kagawa Y; Kawakami J
Clin Chim Acta; 2015 May; 445():79-84. PubMed ID: 25817604
[TBL] [Abstract][Full Text] [Related]
6. 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans.
Diczfalusy U; Nylén H; Elander P; Bertilsson L
Br J Clin Pharmacol; 2011 Feb; 71(2):183-9. PubMed ID: 21219398
[TBL] [Abstract][Full Text] [Related]
7. 4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.
de Graan AJ; Sparreboom A; de Bruijn P; de Jonge E; van der Holt B; Wiemer EA; Verweij J; Mathijssen RH; van Schaik RH
Br J Clin Pharmacol; 2015 Sep; 80(3):560-8. PubMed ID: 26119961
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of effects of indoxyl sulfate and parathyroid hormone on CYP3A activity considering the influence of CYP3A5 gene polymorphisms.
Oda A; Suzuki Y; Yoshijima C; Sato H; Tanaka R; Ono H; Tatsuta R; Ando T; Shin T; Itoh H; Ohno K
Br J Clin Pharmacol; 2023 Dec; 89(12):3648-3658. PubMed ID: 37522799
[TBL] [Abstract][Full Text] [Related]
9. 4β-Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation.
Penzak SR; Rojas-Fernandez C
J Clin Pharmacol; 2019 May; 59(5):611-624. PubMed ID: 30748026
[TBL] [Abstract][Full Text] [Related]
10. Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables.
Aramaki T; Kawakami A; Iwamoto N; Fujikawa K; Kawashiri SY; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Nakashima M; Mizokami A; Furuyama M; Matsuoka N; Ueki Y; Ida H; Origuchi T; Aoyagi K; Eguchi K
Mod Rheumatol; 2009; 19(6):652-6. PubMed ID: 19787419
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the usefulness of plasma 4β-hydroxycholesterol concentration normalized by 4α-hydroxycholesterol for accurate CYP3A phenotyping.
Oda A; Suzuki Y; Sato H; Koyama T; Nakatochi M; Momozawa Y; Tanaka R; Ono H; Tatsuta R; Ando T; Shin T; Wakai K; Matsuo K; Itoh H; Ohno K
Clin Transl Sci; 2024 Mar; 17(3):e13768. PubMed ID: 38465776
[TBL] [Abstract][Full Text] [Related]
12. No impact of vitamin D on the CYP3A biomarker 4β-hydroxycholesterol in patients with abnormal glucose regulation.
Mannheimer B; Wagner H; Östenson CG; Diczfalusy U
PLoS One; 2015; 10(4):e0121984. PubMed ID: 25835492
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio.
Mlugu EM; Minzi OM; Kamuhabwa AAR; Diczfalusy U; Aklillu E
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499500
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the plasma fentanyl and serum 4β-hydroxycholesterol based on CYP3A5 genotype and gender in patients with cancer pain.
Ishida T; Naito T; Sato H; Kawakami J
Drug Metab Pharmacokinet; 2016 Jun; 31(3):242-8. PubMed ID: 27236640
[TBL] [Abstract][Full Text] [Related]
15. 4β-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State.
Wollmann BM; Syversen SW; Lie E; Gjestad C; Mehus LL; Olsen IC; Molden E
Clin Transl Sci; 2017 Jan; 10(1):42-49. PubMed ID: 27991741
[TBL] [Abstract][Full Text] [Related]
16. Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3.
Ito A; Okada Y; Hashita T; Aomori T; Hiromura K; Nojima Y; Nakamura T; Araki T; Yamamoto K
Biochem Genet; 2017 Jun; 55(3):268-277. PubMed ID: 28324194
[TBL] [Abstract][Full Text] [Related]
17. The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.
Størset E; Hole K; Midtvedt K; Bergan S; Molden E; Åsberg A
Br J Clin Pharmacol; 2017 Jul; 83(7):1457-1465. PubMed ID: 28146606
[TBL] [Abstract][Full Text] [Related]
18. Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).
Izumi K; Kaneko Y; Hashizume M; Yoshimoto K; Takeuchi T
PLoS One; 2015; 10(12):e0145468. PubMed ID: 26698858
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4β-hydroxycholesterol in a high-dose vitamin D supplementation study.
Björkhem-Bergman L; Nylén H; Norlin AC; Lindh JD; Ekström L; Eliasson E; Bergman P; Diczfalusy U
Drug Metab Dispos; 2013 Apr; 41(4):704-8. PubMed ID: 23386704
[TBL] [Abstract][Full Text] [Related]
20. Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians.
Gebeyehu E; Engidawork E; Bijnsdorp A; Aminy A; Diczfalusy U; Aklillu E
Pharmacogenomics J; 2011 Apr; 11(2):130-7. PubMed ID: 20231858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
